Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.63B |
| 2 |
Meta Platforms (Facebook)
META
|
+$1.14B |
| 3 |
Oracle
ORCL
|
+$1.04B |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$859M |
| 5 |
S&P Global
SPGI
|
+$832M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$1.17B |
| 2 |
Trade Desk
TTD
|
+$1B |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$895M |
| 4 |
Constellation Brands
STZ
|
+$861M |
| 5 |
Carvana
CVNA
|
+$851M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.43% |
| 2 | Financials | 12.09% |
| 3 | Consumer Discretionary | 8.79% |
| 4 | Healthcare | 8.71% |
| 5 | Communication Services | 6.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MRP
1826
Millrose Properties Inc
MRP
$4.81B
| $49.2M | ﹤0.01% |
+1,856,342
| New | +$43.5M |
|
|
PRMB
1827
Primo Brands
PRMB
$8.54B
| $49.2M | ﹤0.01% |
1,386,268
+148,950
| +12% | +$4.86M |
|
1828
Ambev
ABEV
$46.4B
| $49.2M | ﹤0.01% |
21,106,394
-14,453,910
| -41% | -$28.9M |
|
|
AL
1829
DELISTED
Air Lease Corp
AL
| $49.1M | ﹤0.01% |
1,017,224
+85,848
| +9% | +$4.03M |
|
1830
ARK Genomic Revolution ETF
ARKG
$1.73B
| $49.1M | ﹤0.01% |
2,365,014
-1,119,322
| -32% | -$28.1M |
|
1831
StoneX
SNEX
$7.94B
| $49.1M | ﹤0.01% |
1,445,825
+45,494
| +3% | +$1.53M |
|
1832
Invesco Short Term Treasury ETF
TBLL
$2.85B
| $49.1M | ﹤0.01% |
464,910
+68,215
| +17% | +$7.2M |
|
1833
IAMGOLD
IAG
$10.5B
| $49.1M | ﹤0.01% |
7,850,244
+1,302,227
| +20% | +$7.7M |
|
1834
Alamo Group
ALG
$2.05B
| $49.1M | ﹤0.01% |
275,261
-14,929
| -5% | -$2.74M |
|
1835
State Street SPDR Portfolio Short Term Treasury ETF
SPTS
$6.11B
| $49M | ﹤0.01% |
1,677,107
+74,363
| +5% | +$2.16M |
|
1836
American Airlines Group
AAL
$10.6B
| $49M | ﹤0.01% |
4,648,094
-2,009,094
| -30% | -$30.3M |
|
1837
Nuveen ESG Mid-Cap Value ETF
NUMV
$458M
| $49M | ﹤0.01% |
1,432,975
+262,148
| +22% | +$9.2M |
|
1838
Invesco S&P 500 Momentum ETF
SPMO
$21.8B
| $49M | ﹤0.01% |
529,649
+347,957
| +192% | +$34.1M |
|
1839
Invesco S&P Global Water Index ETF
CGW
$1.08B
| $49M | ﹤0.01% |
879,202
-61,568
| -7% | -$3.4M |
|
1840
Impinj
PI
$5.6B
| $48.9M | ﹤0.01% |
539,569
+5,628
| +1% | +$631K |
|
1841
YPF Sociedad Anonima American Depositary Shares (Each representing ten (10) Class D shares of Capital Stock)
YPF
$19.3B
| $48.9M | ﹤0.01% |
1,395,260
-23,111
| -2% | -$885K |
|
1842
Cohen & Steers Infrastructure Fund
UTF
$3.04B
| $48.8M | ﹤0.01% |
1,911,084
+85,191
| +5% | +$2.08M |
|
1843
Nuveen ESG Small-Cap ETF
NUSC
$1.33B
| $48.8M | ﹤0.01% |
1,271,903
+29,122
| +2% | +$1.21M |
|
1844
iShares US Insurance ETF
IAK
$548M
| $48.6M | ﹤0.01% |
352,460
-67,718
| -16% | -$8.85M |
|
1845
Rambus
RMBS
$11B
| $48.6M | ﹤0.01% |
938,032
+23,282
| +3% | +$1.37M |
|
1846
Clean Harbors
CLH
$16.3B
| $48.6M | ﹤0.01% |
246,328
-60,188
| -20% | -$13.2M |
|
1847
Zymeworks
ZYME
$1.67B
| $48.5M | ﹤0.01% |
4,073,463
-127,974
| -3% | -$1.75M |
|
1848
MINISO
MNSO
$3.75B
| $48.5M | ﹤0.01% |
2,623,388
-51,483
| -2% | -$1.12M |
|
1849
Nuveen ESG Large-Cap Value ETF
NULV
$2.27B
| $48.4M | ﹤0.01% |
1,196,185
+33,464
| +3% | +$1.36M |
|
1850
PTC Therapeutics
PTCT
$6.12B
| $48.4M | ﹤0.01% |
949,434
-124,383
| -12% | -$6.21M |
|
Similar funds
Morgan Stanley's Q1 2025 Portfolio in Review
As of Q1 2025, Morgan Stanley held 8,359 positions worth $1.4T, down 2% from $1.43T the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Morgan Stanley's Q1 2025 filing shows 410 new, 3,433 increased, 3,308 reduced and 270 closed positions. Its largest new stake was Sandisk: 1,632,771 shares worth $77.7M. The largest sale was Intel, an estimated $1.17B.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 23% a quarter earlier, followed by Financials and Consumer Discretionary.
- Morgan Stanley's largest Q1 2025 buy was Sandisk: 1,632,771 shares worth $77.7M.
- Morgan Stanley added most to Invesco QQQ Trust in Q1 2025, an estimated $1.63B increase.
- Morgan Stanley's biggest Q1 2025 reduction was Intel, cutting an estimated $1.17B.
- Morgan Stanley fully exited Inari Medical, Inc. Common Stock in Q1 2025, selling an estimated $110M.
- Morgan Stanley's ten largest holdings make up 20% of its $1.4T portfolio in Q1 2025.
- Morgan Stanley opened 410 new positions and closed 270 in Q1 2025.
- Morgan Stanley's portfolio value fell 2% quarter-over-quarter to $1.4T.
Based on Morgan Stanley's 13F filing for Q1 2025, filed 15 May 2025.